I'm Disgusted Dying People Are Denied Drugs on Cost Grounds; Funding for Vital Treatments on the NHS Can Be a Lottery. Health Reporter HELEN RAE Reports on How One Lifesaving Drug Has Been Deemed Too Exensive

Evening Chronicle (Newcastle, England), April 26, 2008 | Go to article overview
Save to active project

I'm Disgusted Dying People Are Denied Drugs on Cost Grounds; Funding for Vital Treatments on the NHS Can Be a Lottery. Health Reporter HELEN RAE Reports on How One Lifesaving Drug Has Been Deemed Too Exensive


Byline: HELEN RAE

THE partner of a man who died of lung cancer has slammed a decision by not to approve a life-extending drug.

A provisional decision was made by the National Institute for Health and Clinical Excellence (NICE) not to accept oral tablet Tarceva, also known as Erlotinib, as a cost-effective form of treatment for non-small cell lung cancer.

The decision could potentially deny more than 2,000 lung cancer patients in the UK one of their last hopes of treatment.

Today the partner of George Robinson, who was waiting for the drug when he died in 2005, said she was disgusted at the decision. Anne Davis, 68, of Cramlington, said: "I was angry at the time that George was not given Tarceva and I'm angry now at the decision by NICE.

"I think it is disgusting.

There are people out there who desperately need it and they should be given all the support they can get.

This drug can't help George now but it could still save others and it should be seen as a viable option for the health service to prescribe.

"When a relative is diagnosed and dies from lung cancer it is devastating for all involved. I believe if George had been given the drug I'd have had a lot longer with him.

"In many cases Tarceva is very successful and can give a person extra time. I was with George for 12 years and since he died I feel like giving up as I miss him terribly.

"No-one should be denied their last hope of treatment and surely a price cannot be put on a person's life. It's appalling a decision has been based around cost rather than health benefits."

George, 76, died at Wansbeck General Hospital in Ashington after being diagnosed with lung cancer two years earlier.

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
Loading One moment ...
Project items
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited article

I'm Disgusted Dying People Are Denied Drugs on Cost Grounds; Funding for Vital Treatments on the NHS Can Be a Lottery. Health Reporter HELEN RAE Reports on How One Lifesaving Drug Has Been Deemed Too Exensive
Settings

Settings

Typeface
Text size Smaller Larger
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

While we understand printed pages are helpful to our users, this limitation is necessary to help protect our publishers' copyrighted material and prevent its unlawful distribution. We are sorry for any inconvenience.
Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.

Are you sure you want to delete this highlight?